Jul 31, 2025 08:44AM
Jul 31, 2025 08:44AM
Jul 30, 2025 04:05PM
Jul 25, 2025 07:22AM
Jul 25, 2025 07:20AM
Jul 1, 2025 09:50AM
Jun 16, 2025 07:01AM Supernus Pharma (SUPN) to Acquire Sage Therapeutics (SAGE)
Jun 16, 2025 07:00AM
Apr 29, 2025 04:05PM
Apr 15, 2025 06:30AM
Mar 17, 2025 03:01PM
Mar 14, 2025 01:29PM
Mar 13, 2025 06:21PM
Mar 12, 2025 08:26AM Long-Term Shareholder Notice: Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Playstudios, Inc. (NASDAQ: MYPS); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar La
Mar 10, 2025 08:05AM
Mar 8, 2025 01:56PM
Mar 4, 2025 04:16PM
Mar 4, 2025 04:15PM
Feb 11, 2025 04:05PM
Jan 28, 2025 04:30PM
Jan 27, 2025 09:20AM Sage Therapeutics Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen’s Unsolicited Acquisition Proposal
Jan 24, 2025 01:38PM
Jan 13, 2025 07:42AM
Jan 12, 2025 06:00PM
Jan 10, 2025 06:49PM
Jan 8, 2025 06:30AM
Dec 31, 2024 12:50PM
Nov 26, 2024 07:00AM Sage Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
Nov 20, 2024 06:30AM
Nov 20, 2024 06:30AM
Oct 30, 2024 06:42AM
Oct 29, 2024 04:05PM
Oct 17, 2024 07:01AM
Oct 17, 2024 07:00AM
Oct 15, 2024 06:30AM Sage Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024
Oct 8, 2024 06:30AM
Oct 8, 2024 06:30AM
Sep 26, 2024 07:01AM
Sep 26, 2024 07:00AM
Jul 31, 2024 04:05PM
Jul 24, 2024 06:32AM
Jul 24, 2024 06:30AM Sage Therapeutics and Biogen Announce Topline Results from Phase 2 KINETIC 2 Study of SAGE-324 (BIIB124) for the Treatment of Essential Tremor
Jul 17, 2024 06:30AM
Jun 11, 2024 06:31AM
Jun 11, 2024 06:30AM
Jun 5, 2024 06:30AM
May 7, 2024 06:30AM
Apr 25, 2024 06:30AM
Apr 17, 2024 06:31AM SAGE Therapeutics (SAGE) Reports Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor
Apr 17, 2024 06:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All